MEI Pharma names new chief compliance officer
8 July 2021 -

MEI Pharma Inc (NASDAQ: MEIP), a US-based late-stage pharmaceutical company, announced on Wednesday that it has named Tina C Beamon, JD as its new chief compliance officer, effective immediately.

In the new role, Beamon will be responsible for the enterprise-wide compliance programs that manage risks associated with core business activities.

Beamon has more than 20 years of legal and compliance experience across the healthcare and pharmaceutical industry. She has served as chief compliance officer at Karyopharm Therapeutics Inc, executive director of compliance and ethics at Alexion Pharmaceuticals and as senior counsel at Boehringer Ingelheim Pharmaceuticals. She has a bachelor's degree from University of Connecticut and a JD degree from Washington and Lee University School of Law.